State Street Corp Bio Sig Technologies, Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.4 - $1.39 $27,720 - $96,327	69,300 Added 64.12%	177,373 $86,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $1.22 $2,709 - $5,246	4,300 Added 4.14%	108,073 $71,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $4.75 $800,797 - $1.29 Million	-272,380 Reduced 72.41%	103,773 $401,000
Q1 2021 May 17, 2021	BUY	$3.99 - $5.53 $92,105 - $127,654	23,084 Added 6.54%	376,153 $1.62 Million
Q4 2020 Feb 16, 2021	BUY	$2.99 - $5.79 $22,753 - $44,061	7,610 Added 2.2%	353,069 $1.38 Million
Q3 2020 Nov 10, 2020	BUY	$4.79 - $9.1 $158,611 - $301,328	33,113 Added 10.6%	345,459 $1.7 Million
Q2 2020 Aug 14, 2020	BUY	$3.61 - $11.84 $120,292 - $394,532	33,322 Added 11.94%	312,346 $2.25 Million
Q1 2020 May 11, 2020	BUY	$2.56 - $6.14 $714,301 - $1.71 Million	279,024 New	279,024 $1.17 Million

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $81.6M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.